Clinical trials
Phase 2 Alzheimer Disease trials in Argentina
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
| Completed | 4 |
| Recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Alector Inc. | 2 |
| Celgene | 1 |
| Hoffmann-La Roche | 1 |
| MapLight Therapeutics | 1 |
| Pfizer | 1 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 13 |
| Dementia | 4 |
| Brain Diseases | 3 |
| Central Nervous System Diseases | 3 |
| Mental Disorders | 3 |
| Nervous System Diseases | 3 |
| Hallucinations | 1 |
| Neurocognitive Disorders | 1 |
| Neurodegenerative Diseases | 1 |
| Psychomotor Agitation | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.